OnKure Therapeutics, Inc. (OKUR)

NASDAQ

$2.32

$+0.15

(+6.44%)

Regular Market

OnKure Therapeutics, Inc. (OKUR) Live Price Chart

Last updated: ⁦2026-10-20 16:20:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

OnKure Therapeutics, Inc. (OKUR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.32, with a market capitalization of $85.04M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.01 to $5.38. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$85.04M
Open	$2.25
Day's High	$20.00
Day's Low	$1.70
Previous Close	$2.25
Volume	71.60K
Average Volume	247.51K
P/E Ratio	--
52-Week High	$5.38
52-Week Low	$2.01
Dividend Yield	--
Earnings Date	--

OnKure Therapeutics, Inc. (OKUR) Stock Price Today

OnKure Therapeutics, Inc. (OKUR) is currently trading at $2.32 as of 2026-10-20 16:17:00, up 3.16% ($0.07) from the previous close of $2.25

During today's regular trading session, OKUR has traded between $1.70 and $20.00, with a trading volume of 71.60K shares. The current price is near the lower end of today's range.

OnKure Therapeutics, Inc. (OKUR) 7-Day Stock Price Change

Over the past seven days, OnKure Therapeutics, Inc. (OKUR) moved from $2.41 to $2.32, representing a decline of 3.69% ($0.09).

The stock traded between $2.01 and $2.47 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 372.41 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

OKUR 52-Week Price Position

Position in Range: 9.2%

52W Low$2.01

52W High$5.38

OKUR is currently trading at $2.32, placing it 9.2% of the way from its 52-week low of $2.01 to its 52-week high of $5.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is OnKure Therapeutics, Inc. (OKUR)?

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

OnKure Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	45
Exchange	NASDAQ
Company Website	https://www.onkuretherapeutics.com

How to Buy OnKure Therapeutics, Inc. (OKUR) Stock on MEXC

Eligible investors can buy real shares of OnKure Therapeutics, Inc. (OKUR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for OKUR and Place Your Order

Open the RealStocks trading page and search for OKUR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is OnKure Therapeutics, Inc. (OKUR) stock price today?

OnKure Therapeutics, Inc. (OKUR) is currently trading at $ 2.32, up 3.16% ($0.07) from the previous close of $ 2.25. Intraday prices update in real time during regular trading hours.

2.Is OKUR stock going up or down today?

As of 2026-10-20 16:17:00, OKUR is trading at $ 2.32, up 3.16% ($0.07) from its previous close of $ 2.25. The stock has traded between $ 1.70 and $ 20.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is OKUR pre-market price?

As of 2026-10-20 16:17:00, OKUR is trading at $ 2.23 in pre-market trading, down 0.89% ($0.02) from the previous close of $ 2.25. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is OKUR after-hours price?

As of 2026-10-20 16:17:00, OKUR is trading at $ 2.25 in after-hours trading, unchanged from the regular-session close of $ 2.25. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is OKUR stock trading now?

OKUR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does OKUR sit relative to its 52-week high and low?

Over the past 52 weeks, OKUR has traded between a low of $ 2.01 and a high of $ 5.38. At $ 2.32, the stock is positioned 9.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is OnKure Therapeutics, Inc. in?

OnKure Therapeutics, Inc. (OKUR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is OnKure Therapeutics, Inc.'s market capitalization and where is it listed?

OnKure Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 85.04M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is OKUR valued in terms of P/E ratio and EPS?

OKUR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.45. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does OnKure Therapeutics, Inc. pay a dividend?

OnKure Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.